Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03021707 · ClinicalTrials.gov registry record · NA
Early Feasibility Study of UV-Femtosecond Laser Assisted Lenticular Extraction
A NA study of Refractive Error - Myopia Severe and Refractive Error - Myopia Simple, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
- 4
- Study locations
NCT03021707 is a NA study of Refractive Error - Myopia Severe and Refractive Error - Myopia Simple that has completed, run by Alcon Research. The registered enrollment target is 7 participants. The trial reports 4 study locations across 3 states.
The verdict
NCT03021707, a NA study of Refractive Error - Myopia Severe and Refractive Error - Myopia Simple, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to evaluate the initial safety of the UV-FS laser in humans.
Conditions Studied
Interventions
- DEVICE WaveLight® Ultraviolet Femtosecond (FS) Laser System
- PROCEDURE Laser Assisted Lenticular Extraction
Study Locations (4)
Other
- Alcon Investigative Site - Dublin
- Alcon Investigative Site - Singapore
South Dakota
- Alcon Investigative Site - Sioux Falls
Texas
- Alcon Investigative Site - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-03-07 |
| Est. Completion | 2019-10-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03021707
The ClinicalTrials.gov registry entry for NCT03021707 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Refractive Error - Myopia Severe appearing as the primary indexed condition, and to 2 interventions - of which WaveLight® Ultraviolet Femtosecond (FS) Laser System is the first listed.
NCT03021707 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Other, South Dakota, Texas.
Frequently Asked Questions
What is clinical trial NCT03021707 about?
NCT03021707 is a clinical study titled "Early Feasibility Study of UV-Femtosecond Laser Assisted Lenticular Extraction". The purpose of this study is to evaluate the initial safety of the UV-FS laser in humans.
What is the current status of trial NCT03021707?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2017-03-07. Estimated completion is 2019-10-17.
What conditions does trial NCT03021707 study?
This clinical trial studies the following conditions: Refractive Error - Myopia Severe, Refractive Error - Myopia Simple.
What interventions are being tested in trial NCT03021707?
The interventions under investigation include: WaveLight® Ultraviolet Femtosecond (FS) Laser System (DEVICE), Laser Assisted Lenticular Extraction (PROCEDURE).
Who is sponsoring clinical trial NCT03021707?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03021707 being conducted?
This trial has 4 study locations across South Dakota, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Refractive Error - Myopia Severe
All registered trials for this condition
Refractive Error - Myopia Simple
All registered trials for this condition
South Dakota
All trials with a study site in South Dakota
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.